In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...
SurvivorNet on MSN
Targeted drug Epkinly is suddenly front & center in lymphoma care: Here’s what patients need to know
The FDA approved Epkinly in combination with other standard lymphoma drugs, rituximab + lenalidomide, for relapsed or ...
Non-Hodgkin’s lymphoma is a common type of blood cancer with several subtypes that require different treatments and have different outlooks. Non-Hodgkin’s lymphoma (NHL), sometimes just called ...
Classifying non-Hodgkin lymphoma (NHL) can be confusing because there are so many types. The World Health Organization system is often used. It groups NHL by the appearance of the lymphoma cells, the ...
September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...
AYA lymphoma patients often experience delayed diagnosis due to transitional life stages and lack of primary care or insurance. Lymphoma types and presentations in AYAs differ from those in children ...
In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de novo large B-cell lymphoma (LBCL), CAR T-cell therapy showed superior ...
—The subtype of lymphoma and the timing of anticancer treatment was shown to directly affect the level of seroconversion in cancer patients administered COVID vaccination. Reviewed by Catherine E. Lai ...
The immune system produces immune cells that travel through the lymphatic system to fight off infections and diseases. T-cell lymphoma is a type of blood cancer that affects specific immune cells ...
Lymphoma is the third most common cancer in US children, with Hodgkin and non-Hodgkin types affecting them differently. Common symptoms include swollen lymph nodes, fever, and fatigue, with diagnosis ...
The Global Peripheral T-Cell Lymphoma Market is poised for significant growth, driven by a rising incidence of lymphoma and adoption of novel targeted therapies and immunotherapies. Peripheral T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results